Activation of renal signaling pathways in db/db mice with type 2 diabetes

被引:89
|
作者
Feliers, D
Duraisamy, S
Faulkner, JL
Duch, J
Lee, AV
Abboud, HE
Choudhury, GG
Kasinath, BS
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Med, Div Nephrol, San Antonio, TX 78229 USA
[2] GRECC, S Texas Vet Hlth Care Syst, San Antonio, TX USA
关键词
diabetic nephropathy; insulin receptor; phosphotidylinositol; 3-kinase; MAP kinase; Akt; receptor signaling; renal cortex;
D O I
10.1046/j.1523-1755.2001.060002495.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Altered regulation of signaling pathways may contribute to the pathogenesis of renal disease. We examined renal cortical signaling pathways in type 2 diabetes. Methods. The status of renal cortical signaling pathways was examined in control and db/db mice with type 2 diabetes in the early phase of diabetic nephropathy associated with renal matrix expansion and albuminuria. Results. Tyrosine phosphorylation of renal cortical proteins was increased in diabetic mice. Renal cortical activities of phosphatidylinositol 3-kinase (PI 3-kinase) in antiphosphotyrosine immunoprecipitates. Akt (PKB), and ERK1/2-type mitogen-activated protein (MAP) kinase activities were significantly augmented sixfold (P < 0.01), twofold (P < 0.0003), and sevenfold (P < 0.001). respectively, in diabetic mice compared with controls. A part of the increased renal cortical PI 3-kinase activity was due to insulin receptor activation. as PI 3-kinase activity associated with beta chain of the insulin receptor was increased nearly fourfold(P < 0.0235). Additionally. the kinase activity of the immunoprecipitated insulin receptor P chain was augmented in the diabetic renal cortex, and tyrosine phosphorylation of the insulin receptor was increased. In the liver, activities of PI 3-kinase in the antiphosphotyrosine immunoprecipitates and Akt also were increased threefold (P < 0.05) and twofold (P < 0.0002), respectively. However, there was no change in the hepatic insulin receptor-associated PI 3-kinase activity. Additionally, the hepatic ERK1/2-type MAP kinase activity was inhibited by nearly 50% (P < 0.01). Conclusions. These studies demonstrate that a variety of receptor signaling pathways are activated in the renal cortex of mice with type 2 diabetes, and suggest a role for augmented insulin receptor activity in nephropathy of type 2 diabetes.
引用
收藏
页码:495 / 504
页数:10
相关论文
共 50 条
  • [1] Renal cortical Akt (PKB) kinase activation in db/db mice with type 2 diabetes
    Faulkner, JL
    Feliers, D
    Durasaimy, S
    Choudhury, GG
    Abboud, HE
    Kasinath, BS
    DIABETES, 2000, 49 : A154 - A154
  • [2] Saroglitazar Delays and Prevents Type 2 Diabetes in db/db Mice
    Giri, Suresh R.
    Bhoi, Bibhuti B.
    Trivedi, Chitrang J.
    Rath, Akshyaya C.
    Rathod, Rohan M.
    Jain, Mukul R.
    DIABETES, 2018, 67
  • [3] Chlorogenic Acid Improves Late Diabetes through Adiponectin Receptor Signaling Pathways in db/db Mice
    Jin, Shasha
    Chang, Cuiqing
    Zhang, Lantao
    Liu, Yang
    Huang, Xianren
    Chen, Zhimin
    PLOS ONE, 2015, 10 (04):
  • [4] Olmesartan improves cardiovascular complications of type 2 diabetes in db/db mice
    Dong, Yi-Fei
    Yamamoto, Eiichiro
    Kataoka, Kiichiro
    Nakamura, Taishi
    Ogawa, Hisao
    Mitsuyama-Kim, Shokei
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 88P - 88P
  • [5] Skeletal muscle dysfunction in the db/db mice model of type 2 diabetes
    Bayley, Jeppe Seamus
    Pedersen, Thomas Holm
    Nielsen, Ole Bkgaard
    ACTA PHYSIOLOGICA, 2015, 215 : 55 - 55
  • [6] IMPROVEMENT EFFECTS OF CHLOROGENIC ACID ON LATE DIABETES THROUGH ADIPONECTIN RECEPTOR SIGNALING PATHWAYS IN DB/DB MICE
    Chang, C.
    Jin, S.
    Zhang, L.
    Liu, Y.
    Huang, X.
    Chen, Z.
    ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 245 - 245
  • [7] Klotho protein supplementation reduces blood pressure and renal hypertrophy in db/db mice, a model of type 2 diabetes
    Takenaka, Tsuneo
    Kobori, Hiroyuki
    Miyazaki, Takashi
    Suzuki, Hiromichi
    Nishiyama, Akira
    Ishii, Naohito
    Yamashita, Maho
    Hayashi, Matsuhiko
    ACTA PHYSIOLOGICA, 2019, 225 (02)
  • [8] Remission of type 2 diabetes in diabetic db/db mice by betacellulin gene therapy
    Shin, Seungjin
    Kim, Jinsil
    Lim, Yong
    Han, Jaeseok
    Jun, Hee-Sook
    DIABETES, 2007, 56 : A454 - A454
  • [9] Rapamycin Increases Mortality in db/db Mice, a Mouse Model of Type 2 Diabetes
    Sataranatarajan, Kavithalakshmi
    Ikeno, Yuji
    Bokov, Alex
    Feliers, Denis
    Yalamanchili, Himabindu
    Lee, Hak Joo
    Mariappan, Meenalakshmi M.
    Tabatabai-Mir, Hooman
    Diaz, Vivian
    Prasad, Sanjay
    Javors, Martin A.
    Choudhury, Goutam Ghosh
    Hubbard, Gene B.
    Barnes, Jeffrey L.
    Richardson, Arlan
    Kasinath, Balakuntalam S.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2016, 71 (07): : 850 - 857
  • [10] Type 2 Diabetes Leads to Axon Initial Segment Shortening in db/db Mice
    Yermakov, Leonid M.
    Drouet, Domenica E.
    Griggs, Ryan B.
    Elased, Khalid M.
    Susuki, Keiichiro
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2018, 12